StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ATRAV.HE$14.62+0.68%
Fair $14.62+0.0%

ATRAV.HE

Atria Oyj

Consumer Defensive / Packaged FoodsHelsinki

$14.62

+0.10 (+0.68%)

Fairly Valued+0.0%Fair Value $14.62Fund rank 29/100 · Data gapFallback financials|
SA 43/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $53.7M · quality 51.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 27/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · ATRAV.HELocal privado en este navegador · Atria Oyj
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$413M

P/E

9.7x

↓

EV/EBITDA

9.2x

↑

ROE

9.4%

↑

Gross Margin

10.9%

↓

Debt/Equity

0.58

↑
52-Week Range$15
$13$19

TradingView lightweight chart

ATRAV.HE price, volumen y niveles de valoración

Último $14.90Periodo +192.2%
Fair value: $14.62

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+2.2%

FCF CAGR

—

FCF margin

3.6%

FCF / Net income

1.62x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.81B · net income $40.7M · FCF $65.9M

2022-FY → 2025-FY

Gross margin

10.9%+1.0% pts

Operating margin

3.5%+0.7% pts

Net margin

2.2%+2.6% pts

FCF margin

3.6%+7.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.81B$1.81B$1.76B$1.75B$1.70B
Net Income$40.7M$40.7M$39.7M$-19.8M$-5.3M
EBITDA$68.3M$68.3M$73.2M$8.5M$9.7M
EPS1.441.441.41-0.70-0.19
Gross Margin10.9%10.9%10.9%9.8%9.9%
Operating Margin3.5%3.5%3.6%2.5%2.9%
Net Margin2.2%2.2%2.3%-1.1%-0.3%
Balance Sheet
Debt/Equity0.580.580.700.730.59
Current Ratio1.051.05———
Cash Flow
Free Cash Flow$65.9M$65.9M$53.7M$-16.3M$-72.6M
Returns
ROE9.4%9.4%9.9%-5.1%-1.2%
Valuation
P/E9.689.687.87——
EV/EBITDA9.249.247.8567.6151.98
P/B0.950.950.780.770.59
Growth & Yield
Revenue Growth3.3%3.3%0.2%3.3%—
EPS Growth2.1%2.1%301.4%-268.4%—
Dividend Yield5.0%5.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-3.4%

fácil

EPS terminal req.

$1.30

Spread vs growth

5.5%

5Y implied EPS CAGR

1.7%

fácil

EPS terminal req.

$1.57

Spread vs growth

0.4%

10Y implied EPS CAGR

5.8%

razonable

EPS terminal req.

$2.53

Spread vs growth

-3.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +23.3%

Total return

+23.3%

Start / end P/E

8.9x → 10.3x

EPS bridge

1.41 → 1.44

Residual

+0.3%

EPS growth+2.1%
Multiple rerating+15.8%
Dividend+5.0%
Residual / FX / buybacks / cross-term+0.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.